Angelo P. Creticos, M.D. Cancer Center

Chicago, Illinois 60657

0 studies enrolling now · 2 studies all time

What they study most

Drug/Agent Toxicity by Tissue/Organ, Leukemia, Myelodysplastic Syndromes, Neutropenia

Studies at this site

• Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML — Withdrawn before enrolling
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia — Withdrawn before enrolling